Petra Kaufmann - 03 Mar 2025 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Chief Medical Officer
Signature
/s/ Michael Cohen, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 17:09:51 UTC
Previous filing
20 Mar 2024
Next filing
05 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Award (Right to Buy) Award $0 +144,000 $0.000000 144,000 03 Mar 2025 Common Stock 144,000 $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 3, 2025.